By enabling rapid microbial growth in high‑methanol conditions, the strain lowers feedstock waste and operating costs, making sustainable biomanufacturing financially competitive with fossil‑based processes.
The push toward carbon‑neutral chemicals has placed methanol, a low‑cost C1 substrate, at the center of next‑generation biorefineries. Yet most microbes stall or die when methanol exceeds 1 % (v/v), limiting productivity and inflating capital costs. The UNIST team’s methanol‑tolerant *Methylobacterium extorquens* strain breaks that barrier, thriving at 2.5 % methanol while maintaining a 1.7‑fold faster growth rate than traditional hosts. This capability directly addresses the key economic hurdle of substrate inhibition, opening a realistic pathway for large‑scale, low‑price bio‑manufacturing.
The researchers employed adaptive laboratory evolution, incrementally raising methanol concentrations to select for resilient phenotypes. Whole‑genome sequencing pinpointed recurrent mutations in *metY*, which mitigates toxic intermediate accumulation, and *kefB*, which optimizes potassium‑driven energy balance. Functional assays confirmed that these alterations jointly enhance detoxification and energy efficiency, the twin bottlenecks in methanol metabolism. By providing a genetic blueprint, the study accelerates the design‑build‑test cycle for C1‑based microbes, allowing engineers to replicate or improve tolerance without months of trial‑and‑error evolution.
From a commercial perspective, the new strain could shrink operating expenses for bioplastic, organic‑acid, and specialty‑chemical production by reducing feedstock waste and shortening fermentation times. Lowered capital intensity makes methanol‑derived routes competitive with petrochemical baselines, encouraging investment in sustainable supply chains. Moreover, the identified targets are transferable to other industrial microbes, amplifying the impact across multiple product families. As policy incentives favor low‑carbon processes, the ability to commercialize methanol‑based biomanufacturing at scale positions companies to capture emerging market share while meeting climate goals.
Comments
Want to join the conversation?
Loading comments...